公开(公告)号：US20240139105A1

公开(公告)日：2024-05-02

申请号：US18274955

申请日：2022-01-27

申请人： CENTRO DE INGENIERÍA GENÉTICA Y BIOTECNOLOGÍA

发明人： Jesús Hector SANTANA MILIAN ,  Francisco HERNANDEZ BERNAL ,  Sonia GONZALEZ BLANCO ,  Yasser ZARATE RIVERA ,  Mercedes Dania BACARDÍ FERNÁNDEZ ,  Diana GARCIA DEL BARCO HERRERA ,  Yaima GONZÁLEZ GONZÁLEZ ,  Raúl Fidel CASTRO ODIO ,  Jorge Amador BERLANGA ACOSTA ,  Gerardo Enrique GUILLEN NIETO ,  Juan VALIENTE MUSTELIER

IPC分类号： A61K9/08 ,  A61K9/00 ,  A61K9/19 ,  A61K38/08 ,  A61K47/12 ,  A61K47/26 ,  A61P9/10

CPC分类号： A61K9/08 ,  A61K9/0019 ,  A61K9/19 ,  A61K38/08 ,  A61K47/12 ,  A61K47/26 ,  A61P9/10

摘要： Pharmaceutical composition comprising growth-hormone releasing peptide 6 (GHRP-6), tartrate buffer at pH 5.0-6.0, and trehalose as stabilizing agent, as well as the use of said composition for the manufacture of a medicament. The invention also provides a kit of parts comprising said pharmaceutical composition and a method of treatment of an individual in need thereof, which entails the administration of a therapeutically effective amount of the pharmaceutical composition comprising of GHRP-6, tartrate buffer at pH 5.0-6.0 and trehalose.